State scrutiny of pharma price mark-ups may lead to review of TMR policy – FinSiddhi
Business News

State scrutiny of pharma price mark-ups may lead to review of TMR policy

Business Standard

Drug regulators in Maharashtra, Karnataka and Uttar Pradesh are gathering data on price mark-ups, potentially strengthening the case for a review of trade margin rationalisation
Read more at Business Standard

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Related Posts

Shein targets September 1 for Hong Kong IPO: Report

Shein has set its Hong Kong initial public offering for September 1, a slight delay from earlier projections. The company’s growth has slowed, and rising costs are impacting investor interest. Shein aims for a valuation between $26 billion and $27 billion, a considerable drop compared to its 2022 fundraising figures.

Seattle shipbuilder’s 2,700-acre gift created Moran State Park in 1921

Faced with health challenges in 1905, Seattle shipbuilder Robert Moran moved to the serene Orcas Island, selling his company for $3.5 million. He went on to build Rosario mansion and, in 1921, contributed over 2,700 acres to Washington state, establishing Moran State Park, which has grown into a vital recreational space. Robert Moran passed away…